SEC Form 4 · accession 0001144204-16-099376
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip P. Chan
Officer — President and CEO · Director
Period of report
Sep 9, 2015
Accepted (ET)
May 6, 2016 · 8:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2015 | J | 9,879 | $0.00 | A | 85,322 | D | |
| Common Stock | Dec 30, 2015 | J | 2,903 | $0.00 | A | 88,225 | D | |
| Common Stock | May 4, 2016 | J | 19,757 | $0.00 | A | 107,982 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution from NJTC Investment Fund, LP, of which the reporting person is a non-managing limited partner.